Related Experiment Video
Updated: Jan 21, 2026

Mapping Genome-wide Accessible Chromatin in Primary Human T Lymphocytes by ATAC-Seq
Published on: November 13, 2017
Global changes in chromatin accessibility and transcription following ATRX inactivation in human cancer cells
Junbo Liang1, Hongchao Liu1, Guangyu Li1
1State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Abstract:
α-Tthalassemia mental retardation X-linked (ATRX) is a chromatin remodeler frequently mutated in many cancers. Despite the binding pattern of ATRX in heterochromatin, ATRX-mediated epigenomic changes in cancer cells have not been profiled, especially for the heterochromatin regions. Here, we profiled genome-wide maps of chromatin accessibility in ATRX-intact and ATRX-null human cancer cells. We found extensive changes in chromatin accessibility in both repetitive DNA regions and non-repetitive regulatory regions following ATRX loss. These changes are highly correlated with changes in transcription, which lead to alterations in cancer-related signalling pathways, such as upregulation of the TGF-β pathway and downregulation of the cadherin family of proteins. These findings indicate that ATRX deficiency induces epigenomic changes and promotes tumorigenesis through both genome instability and shifts in transcription.
Insights
Loss of alpha-thalassemia mental retardation X-linked (ATRX) causes widespread epigenomic changes in cancer cells, affecting repetitive DNA and regulatory regions. ATRX deficiency promotes tumorigenesis via genome instability and altered gene transcription.
Area of Science:
- Cancer Biology
- Epigenetics
- Chromatin Remodeling
Background:
- Alpha-thalassemia mental retardation X-linked (ATRX) is a chromatin remodeler frequently mutated in various cancers.
- While ATRX binds to heterochromatin, its specific epigenomic impact, particularly in these regions, remains largely uncharacterized in cancer cells.
Purpose of the Study:
- To profile genome-wide chromatin accessibility changes in human cancer cells with and without ATRX.
- To investigate the epigenomic consequences of ATRX loss, focusing on heterochromatin and regulatory elements.
Main Methods:
- Genome-wide chromatin accessibility mapping (e.g., ATAC-seq or similar) was performed on isogenic ATRX-intact and ATRX-null human cancer cell lines.
- Analysis correlated changes in chromatin accessibility with gene expression data.
Main Results:
- ATRX loss led to extensive alterations in chromatin accessibility across both repetitive DNA and non-repetitive regulatory regions.
- These accessibility changes were strongly correlated with significant shifts in gene transcription.
- Key cancer-related signaling pathways were affected, including upregulation of TGF-β signaling and downregulation of cadherin proteins.
Conclusions:
- ATRX deficiency induces substantial epigenomic alterations in cancer cells.
- These ATRX-mediated changes contribute to tumorigenesis by promoting genome instability and altering transcriptional programs, impacting critical cancer pathways.
Related Concept Videos
X-Inactivation
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Chromatin Packaging
The chromatin
In combination with specialized DNA binding protein called Histones, the DNA double helix forms a compact DNA: protein complex called chromatin. The chromatin itself is further compacted into higher-order...
Inheritance of Chromatin Structures
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

